Showing results (41-50 of 72) with videos related to
Sort By:
Pageof 8
Annals of Translational Medicine|February 12, 2020
The effect of histological subtypes on survival outcome in nasopharyngeal carcinoma after extensive follow upSan-Gang Wu, Chen-Lu Lian, Jun Wang, et al.Breast (Edinburgh, Scotland)|January 10, 2020
Should women with early breast cancer under 40 years of age have a routine 21-gene recurrence score testing: A SEER database studyKai-Hua Liu, Lei Zhang, Jian-Xian Chen, et al.Future Oncology (London, England)|August 15, 2019
The 1-year mortality after radiotherapy for nasopharyngeal carcinoma: a population-based analysisSan-Gang Wu, Wen-Wen Zhang, Jun Wang, et al.BJS Open|April 25, 2022
Impact of AJCC prognostic staging on prognosis and postmastectomy radiotherapy decision-making in hormone receptor-positive and HER2-positive breast cancerGuan-Qiao Li, Yang Yu, Wen-Wen Zhang, et al.JMIR Medical Informatics|November 17, 2020
Analysis of the Trends in Publications on Clinical Cancer Research in Mainland China from the Surveillance, Epidemiology, and End Results (SEER) Database: Bibliometric StudyMin-Qiang Lin, Chen-Lu Lian, Ping Zhou, et al.Cancer Medicine|February 15, 2021
Additional radiotherapy to breast-conserving surgery is an optional treatment for de novo stage IV breast cancer: A population-based analysisJun Wang, Shi-Ping Yang, Ping Zhou, et al.Biomarkers in Medicine|June 26, 2019
Progesterone receptor status and tumor grade predict the 21-gene recurrence score of invasive lobular breast cancerSan-Gang Wu, Wen-Wen Zhang, Jun Wang, et al.Breast (Edinburgh, Scotland)|March 16, 2020
Evaluation of the 8th edition of the American joint committee on cancer's pathological staging system in prognosis assessment and treatment decision making for stage T1-2N1 breast cancer after mastectomySan-Gang Wu, Jun Wang, Chen-Lu Lian, et al.Plos One|January 4, 2014
Antimicrobial susceptibility of standard strains of nontuberculous mycobacteria by microplate Alamar Blue assayGuilian Li, Lu-Lu Lian, Li Wan, et al.Radiation Oncology (London, England)|September 21, 2021
Increased risk of cerebrovascular mortality in head and neck cancer survivors aged ≥ 65 years treated with definitive radiotherapy: a population-based cohort studyQing-Song He, Zhen-Ping Wang, Zhao-Jun Li, et al.Pageof 8